JPRN-UMIN000006149已完成未知
The Japan Hypertension Evaluation with Angiotensin 2 Antagonist Losartan Therapy - J-HEALTH study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- MSD KK
- 入组人数
- 30,000
研究概览
简要总结
Blood pressure was well controlled during the study period by losartan alone or losartan-based combination therapy.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with a history of losartan treatment at any period were excluded from the study
研究者
相似试验
已完成
4 期
Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)HypertensionNCT00140959Organon and Co120
已完成
3 期
BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)HypertensionNCT00546754Organon and Co808
Unknown
4 期
Fixed-Free HTN TrialHypertensionNCT03578042Hotel Dieu de France Hospital100
已完成
4 期
18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 DiabeticsHypertensionType 2 DiabetesNCT00654745Daiichi Sankyo207
已完成
4 期
Effect of Termisartan or Losartan in Hypertensive Diabetic Patients with MacroalbumiuriaJPRN-UMIN000000797Saitama Medical University100